![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Invitrogen Corporation Carlsbad Us, based in India, is a pharmaceutical company.
One of their significant offerings is Bovine Thrombin, (New Zealand origin), supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-268 - Rev 03
This TSE Type CEP, issued on May 13, 2005, remains in force until March 29, 2006, ensuring its reliability within the pharmaceutical industry.